National Health Investors, Inc. Experiences Revision in Its Stock Evaluation Metrics

National Health Investors, Inc., a small-cap player in the realty sector, has recently undergone a valuation adjustment. The company's current P/E ratio stands at 24, while its price-to-book value is reported at 2.44. Other key financial metrics include an EV to EBIT of 18.42 and an EV to EBITDA of 13.14. The company also boasts a notable dividend yield of 435.03%, alongside a return on capital employed (ROCE) of 13.35% and a return on equity (ROE) of 10.17%. In comparison to its peers, National Health Investors presents a mixed performance. For instance, Macerich Co. is categorized as risky, while Tanger, Inc. is noted for its high valuation metrics. COPT Defense Properties also shows a higher valuation, whereas Broadstone Net Lease, Inc. stands out as very attractive. The company's stock performance has varied over different time frames, with a year-to-date return of 15.40%, surpassing the S&P 500's return of 0.94% in the same period. However, over the last three years, National Health Investors has lagged behind the S&P 500, which highlights the competitive landscape in the realty sector.